Xtandi 80 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FQ64P
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,170
Award facts
- Contract value 100% obligated
- $4,169.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 29, 2025, for the supply of Xtandi 80 mg tablets (60-count units). The contract, valued at $4,169.59, is a firm fixed-price delivery order with an ultimate completion date of September 2, 2025. This award was made without set-aside designation, demonstrating the company's competitive position in federal pharmaceutical procurement markets. The place of performance is Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499.999 billion and valid through November 2026. This master contract enables the DLA to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to support Department of Defense healthcare facilities worldwide. Xtandi, an oncology treatment, aligns with the broad portfolio of specialized pharmaceutical products DMS Pharmaceutical Group routinely supplies through this contract vehicle to military health systems.
Quick answers
Who was awarded contract SPE2DB25FQ64P?
SPE2DB25FQ64P was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 29, 2025.
How much is contract SPE2DB25FQ64P worth?
The government has obligated $4,170 on SPE2DB25FQ64P.
Is contract SPE2DB25FQ64P an order under another contract?
Yes. SPE2DB25FQ64P is a delivery order under SPE2DB20D9226, an indefinite delivery contract.
Was contract SPE2DB25FQ64P competed?
The extent of competition for SPE2DB25FQ64P was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award